<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Quarters of Monaco / Monte Carlo / Generic drug / Food and Drug Administration / Monaco / Bioequivalence / Abbreviated New Drug Application / Authorized generics / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology
Date: 2006-05-12 01:26:58
Pharmaceutical industry
Quarters of Monaco
Monte Carlo
Generic drug
Food and Drug Administration
Monaco
Bioequivalence
Abbreviated New Drug Application
Authorized generics
Pharmaceutical sciences
Pharmaceuticals policy
Pharmacology

Add to Reading List

Source URL: www.gpaconferences.com

Download Document from Source Website

File Size: 855,21 KB

Share Document on Facebook

Similar Documents

Pharmacology / Pharmaceutics / Generic drug / Public domain / Ratiopharm / Biosimilar / Abbreviated New Drug Application / Generic brand / Authorized generics / Pharmaceutical industry / Pharmaceutical sciences / Pharmaceuticals policy

PDF Document

DocID: 17rqt - View Document

Generic brand / Brand / No frills / Store brand / Identification / Private label / Online shopping / Authorized generics / Generic drug / Marketing / Business / No Name

THE MACKAY REPORT BRANDS & GENERICS SEPTEMBER[removed]MACKAY RESEARCH

DocID: WrLN - View Document

Pharmacology / Health / Food and Drug Administration / Generic drug / Drug Price Competition and Patent Term Restoration Act / Abbreviated New Drug Application / New Drug Application / Authorized generics / Novartis / Pharmaceutical sciences / Pharmaceuticals policy / Pharmaceutical industry

\\server05\productn\C\COL\108-6\COL604.txt unknown Seq: 1

DocID: RORi - View Document

Health / Pharmacology / Generic drug / Public domain / Drugs / Canadian Institute for Health Information / Prescription medication / Authorized generics / Pharmaceutical policy / Pharmaceuticals policy / Pharmaceutical sciences / Pharmaceutical industry

Analysis Brief Generic Drugs in Canada, 2013 sets a potentially useful benchmark for Canadian generic price levels prior to the full implementation of the Value Price Initiative, which will take place by April 1, 2016.

DocID: MjQv - View Document

Law / Business / Anti-competitive behaviour / Jon Leibowitz / Federal Trade Commission / Government / Authorized generics / Generic drug / United States v. Microsoft / Pharmaceutical industry / Pharmaceuticals policy / United States antitrust law

Lamictal brief April28 final

DocID: DDOO - View Document